• En En
    • Fr Fr
  • Health Science

    Therapeutic Benefits of Medical Cannabis

    Therapeutic Benefits of Medical Cannabis

    Based on current scientific literature, there is therapeutic potential for medical cannabis in a number of medical conditions and we anticipate this list will continue to grow as further research is completed. At Aurora, we are passionate about research. We have 40 scientific studies and publications underway or completed. This includes randomized clinical trials, observational studies and case studies. Many of these studies are in partnership with academic research institutions in Canada and around the world. 

    We recommend you talk to your healthcare practitioner to determine if cannabis could be beneficial for your treatment plan. To learn more about getting started with medical cannabis at Aurora or to find a cannabis-educated healthcare practitioner, visit our Patients page. We’re here to help.

    Learn More About the Therapeutic Potential of Medical Cannabis

    Cannabis and Mental Health:

      • Post-traumatic stress disorder (1)
      • Anxiety (2)

        Cannabis and Oncology

          • Nausea and vomiting (3)
          • Pain (4) 
          Appetite stimulation (5)

            Cannabis and Pain Management

              • Neuropathic pain (6)
              • Chronic pain (7, 8)
              • Sleep (8)

                Other

                  • Epilepsy (9, 10)
                  • Crohn’s disease (11)

                    References:

                    1. Smith, P. A., Chan, S., Blake, A., Wolt, A., Zhang, L., Wan, B. A., … O’Hearn, S. (2017). Medical cannabis use in military and police veterans diagnosed with post-traumatic stress disorder (PTSD). Journal of Pain Management, 10, 397-405. Retrieved from https://www.researchgate.net/publication/324088874 
                    2. Bergamaschi, M. M., Queiroz, R. H., Chagas, M. H., de Oliveira, D. C., De Martinis, B. S., Kapczinski, F., … Crippa, J. A. (2011). Cannabidiol Reduces the Anxiety Induced by Simulated Public Speaking in Treatment-Naïve Social Phobia Patients. Neuropsychopharmacology, 36, 1219-1226. https://doi.org/10.1038/npp.2011.6
                    3. Duran, M., Pérez, E., Abanades, S., Vidal, X., Saura, C., Majem, M., … Capellà, D. (2010). Preliminary efficacy and safety of an oromucosal standardized cannabis extract in chemotherapy-induced nausea and vomiting. British Journal of Clinical Pharmacology, 70, 656-663. https://doi.org/10.1111/j.1365-2125.2010.03743.x
                    4. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan ED, Potts R, Fallon MT. Multicenter, double-blind, randomized, placebo-controlled, parallel-group study of the efficacy, safety, and tolerability of THC:CBD extract and THC extract in patients with intractable cancer-related pain. J Pain Symptom Manage. 2010;39(2):167‐179 https://pubmed.ncbi.nlm.nih.gov/19896326/
                    5. Turcott, J. G., Guillen-Núñez, M. D. R., Flores-Estrada, D., Oñate-Ocaña, L. F., Zatarain-Barrón, Z. L., Barrón, F., & Arrieta, O. (2018). The effect of Nabilone on appetite, nutritional status, and quality of life in lung cancer patients: A randomized, double-blind clinical trial. Supportive Care in Cancer, 26, 3029-3038. https://doi.org/10.1007/s00520-018-4154-9
                    6. Ellis, R. J., Toperoff, W., Vaida, F., van den Brande, G., Gonzales, J., Gouaux, B., … Hampton Atkinson, J. (2009). Smoked medicinal cannabis for neuropathic pain in HIV: A randomized, crossover clinical trial. Neuropyschopharmacology, 34, 672-680. https://doi.org/10.1038/npp.2008.120
                    7. Bellnier, T., Brown, G. W., & Ortega, T. R. (2018). Preliminary evaluation of the efficacy, safety, and costs associated with the treatment of chronic pain with medical cannabis. The Mental Health Clinician, 8, 110-115. https://doi.org/10.9740/mhc.2018.05.110
                    8. Ware, M. A., Wang, T., Shapiro, S., Collet, J-P., Boulanger, A., Esdaile, J. M., … O’Connell, Colleen. (2015). Cannabis for the management of pain: Assessment of safety study (COMPASS). The Journal of Pain, 16, 1233-1242. https://doi.org/10.1016/j.jpain.2015.07.014
                    9. Devinsky, O., Cross, J. H., Laux, L, Marsh, E., Miller, I., Nabbout, R., … Wright, S. (2017). Trial of cannabidiol for drug-resistant seizures in the Dravet syndrome. New England Journal of Medicine, 376, 2011-2020. https://doi.org/10.1056/nejmoa1611618
                    10. Devinsky, O., Patel, A. D., Cross, J. H., Villanueva, V., Wirrell, E. C., Privitera, M., … Zuberi, S. M. (2018). Effect of Cannabidiol on Drop Seizures in the Lennox–Gastaut Syndrome. New England Journal of Medicine, 378, 1888-1897. https://doi.org/10.1056/nejmoa1714631
                    11. Naftali, T., Lev, L. B., Yablekovitz, D., Half, E., & Konikoff, F. M. (2011). Treatment of Crohn’s disease with cannabis: An observational study. The Israel Medical Association Journal, 13, 455-458. Retrieved from https://www.ima.org.il/MedicineIMAJ/viewarticle.aspx?year=2011&month=08&page=455 
                    Previous Article Next Article

                    You must be of legal age in your province of residence to view our content.

                    Go Back

                    • En En
                    • Fr Fr
                    • Better Together
                    Welcome to Aurora. A family of medical cannabis brands.

                    Patient Login

                    Forgot password?

                    This website uses cookies to enable essential features, please review our Cookie Policy for more information on how to manage and personalize your experience.